2.1700
-0.1900
(-8.05%)
At close: 4:00:02 PM EDT
2.1986
+0.03
+(1.32%)
After hours: 5:17:41 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-81,151
-81,151
-59,496
-54,560
-44,182
Investing Cash Flow
-94,077
-94,077
-165
-901
-188
Financing Cash Flow
88,776
88,776
103,791
189
150,857
End Cash Position
38,266
38,266
124,718
80,588
135,860
Interest Paid Supplemental Data
127
127
176
77
--
Capital Expenditure
-481
-481
-165
-901
-188
Issuance of Capital Stock
88,712
88,712
100,251
20
151,060
Issuance of Debt
--
--
4,000
--
--
Repayment of Debt
-410
-410
-425
-163
--
Repurchase of Capital Stock
-17
-17
--
--
--
Free Cash Flow
-81,632
-81,632
-59,661
-55,461
-44,370
12/31/2021 - 11/3/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARTV Artiva Biotherapeutics, Inc.
1.8400
-7.54%
EWTX Edgewise Therapeutics, Inc.
11.57
-7.44%
CYTK Cytokinetics, Incorporated
37.85
+1.42%
ENTO Entero Therapeutics, Inc.
0.4030
-7.89%
BDRX Biodexa Pharmaceuticals Plc
1.5700
+3.97%
RCKT Rocket Pharmaceuticals, Inc.
4.9400
-8.52%
HEPA Hepion Pharmaceuticals, Inc.
0.4311
-11.62%
SGMO Sangamo Therapeutics, Inc.
0.7238
+3.59%
ZVSA ZyVersa Therapeutics, Inc.
0.7713
-25.12%
ONCO Onconetix, Inc.
0.0580
-8.81%